Kiwa Bio-Tech Products Group Corp is a United States-based company that develops, manufactures, distributes and markets bio-technological products for agriculture. The Company operates primarily in the mainland China. Its products include biological organic fertilizer series, compound microbial fertilizer series, biological water-soluble fertilizer series, microorganism bacterium agent series and biological soil remediation series.
Its biological organic fertilizer series include Bio-organic Fertilizer (50 million Bacteria/g), Bio-organic Fertilizer (200 million Bacteria/g) and Bio-organic Fertilizer (1 billion Bacteria/g). Its compound microbial fertilizer series include specialized fertilizers for fruit trees, tea trees, Chinese herbs, flowers, vegetables, tobacco and all crops..
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 18.6K |
| Three Month Average Volume | 1.2M |
| High Low | |
| Fifty-Two Week High | 0.001 USD |
| Fifty-Two Week Low | 0 USD |
| Fifty-Two Week High Date | 01 Nov 2022 |
| Fifty-Two Week Low Date | 07 Jun 2023 |
| Price and Volume | |
| Current Price | 0.0002 USD |
| Beta | 3 |
| Relative Price Change | |
| Four Week Relative Price Change | 2.21% |
| Thirteen Week Relative Price Change | -0.20% |
| Twenty-Six Week Relative Price Change | -63.32% |
| Fifty-Two Week Relative Price Change | -14.85% |
| Year-to-Date Relative Price Change | -40.99% |
| Price Change | |
| One Day Price Change | 0.00% |
| Thirteen Week Price Change | 0.00% |
| Twenty-Six Week Price Change | -60.00% |
| Five Day Price Change | 0.00% |
| Fifty-Two Week Price Change | 0.00% |
| Year-to-Date Price Change | -33.33% |
| Month-to-Date Price Change | 0.00% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 0.11735 USD |
| Book Value Per Share (Most Recent Quarter) | 0.11735 USD |
| Tangible Book Value Per Share (Last Fiscal Year) | 0.11735 USD |
| Tangible Book Value Per Share (Most Recent Quarter) | 0.11735 USD |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | 0.09792 USD |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 1.75723 USD |
| Revenue Per Share (Trailing Twelve Months) | 1.64295 USD |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | -99999.99 USD |
| Dividend Per Share (Trailing Twelve Months) | 0 USD |
| Dividend Per Share (5 Year) | -99999.99 USD |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | -0.29084 USD |
| Excluding Extraordinary Items (Trailing Twelve Months) | -0.22792 USD |
| Normalized (Last Fiscal Year) | -0.19035 USD |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | -0.29084 USD |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | -0.22229 USD |
| Including Extraordinary Items (Last Fiscal Year) | -0.29084 USD |
| Including Extraordinary Items (Trailing Twelve Months) | -0.22792 USD |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 0.0001 USD |
| Cash Per Share (Most Recent Quarter) | 0.0001 USD |
| Cash Flow Per Share (Last Fiscal Year) | -0.28949 USD |
| Cash Flow Per Share (Trailing Twelve Months) | -0.26996 USD |
| Free Cash Flow Per Share (Trailing Twelve Months) | 0.0075 USD |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | -9 |
| Cash Flow Revenue (Trailing Twelve Months) | 0 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | -12.41% |
| Pretax Margin (Last Fiscal Year) | -12.41% |
| Pretax Margin (5 Year) | 0.24% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 17.26% |
| Gross Margin (Trailing Twelve Months) | 17.19% |
| Gross Margin (5 Year) | 23.58% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | -2.96% |
| Operating Margin (Trailing Twelve Months) | -2.96% |
| Operating Margin (5 Year) | 3.92% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | -16.55% |
| Net Profit Margin (Trailing Twelve Months) | -16.55% |
| Net Profit Margin (5 Year) | -4.95% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | -99,999.99% |
| Tangible Book Value (5 Year) | -99,999.99% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | -99,999.99% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | -2.30% |
| Revenue Growth (3 Year) | -99,999.99% |
| Revenue Change (Trailing Twelve Months) | 30.80% |
| Revenue Per Share Growth | -99,999.99% |
| Revenue Growth (5 Year) | 60.92% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | -99,999.99% |
| Total Debt (5 Year) | 3.55% |
| Dividends | |
| Dividend Growth (3 Year) | -99,999.99% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | -909.16% |
| EPS Change (Trailing Twelve Months) | -1,471.36% |
| EPS Growth (3 Year) | -99,999.99% |
| EPS Growth (5 Year) | -99,999.99% |
| EBITDA | |
| EBITDA (5 Year) | -99,999.99% |
| EBITDA (5 Year Interim) | -99,999.99% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -99,999.99% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | 0 |
| Price to Tangible Book (Most Recent Quarter) | 0 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | 0 |
| Price to Free Cash Per Share (Trailing Twelve Months) | 0 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | 2.8M |
| Net Debt (Last Fiscal Year) | 2.8M |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 0 |
| Price to Sales (Trailing Twelve Months) | 0 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | -100,000 |
| PE Normalized (Last Fiscal Year) | -100,000 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | 58 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | 5 |
| PE Including Extraordinary Items (Trailing Twelve Months) | -100,000 |
| Dividends | |
| Dividend Yield (5 Year) | -99,999.99% |
| Dividend Yield | -99,999.99% |
| Current Dividend Yield | 0.00% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | 0 |
| Price to Book (Most Recent Quarter) | 0 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 1 |
| Long Term Debt to Equity (Most Recent Quarter) | 1 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | -99,999.99% |
| Payout Ratio (Trailing Twelve Months) | -99,999.99% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 2 |
| Quick Ratio (Most Recent Quarter) | 2 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | -100,000 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | -100,000 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 2 |
| Current Ratio (Most Recent Quarter) | 2 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | 183.1K |
| Free Cash Flow (Trailing Twelve Months) | 183.1K |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | 1 |
| Net Interest Coverage (Trailing Twelve Months) | 1 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 29 |
| Total Debt to Equity (Most Recent Quarter) | 29 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | -23.45% |
| Return on Assets (Trailing Twelve Months) | -23.45% |
| Return on Assets (5 Year) | -6.84% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | -59.22% |
| Return on Equity (Trailing Twelve Months) | -59.22% |
| Return on Equity (5 Year) | -69.40% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | -58.87% |
| Return on Investment (Trailing Twelve Months) | -58.87% |
| Return on Investment (5 Year) | -57.35% |